Investigating the role of endocannabinoids in endometriosis pathophysiology and determine efficacy of cannabinoids as a novel therapeutic modality.

研究内源性大麻素在子宫内膜异位症病理生理学中的作用，并确定大麻素作为一种新型治疗方式的功效。

• 批准号: 433650
• 负责人: Tayade Chandrakant
• 金额: $ 63.25万
• 依托单位: Queen's University (Kingston, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-10-01 至 2025-10-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=433650&lang=en
• 关键词: Angiogenesis; Cannabinoids; Endometriosis; Inflammation; Pain; Therapuetics

Endometriosis (EM) is a disease where normal lining of the uterus, called endometrium, grows outside on the organs in pelvic cavity. It is estimated to affect ~200 million women worldwide and more than 50% of them experience infertility and disease recurr

子宫内膜异位症 (EM) 是一种子宫内膜（称为子宫内膜）生长在盆腔器官外部的疾病。据估计，它影响了全球约 2 亿女性，其中 50% 以上经历不孕不育和疾病复发